The short- and long-term WD challenges reported above suggested that loss of PARKIN in hepatocytes accelerated the onset of NAFLD, but that over time WT and LKO mice converged phenotypically as NAFLD severity plateaud. Here, PRKN is linked to metabolic dysfunction-associated steatotic liver disease.